Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis [3]

Clinical Rheumatology

Volumn 15, Issue 2, 1996, Pages 218-219

  Spadaro, A ^a   Riccieri, V ^a   Sili Scavalli, A ^a   Sensi, F ^a   Taccari, E ^a   Zoppini, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; METHOTREXATE;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SOLUBILITY;

EID: 0029878260     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02230349     Document Type: Letter

References (0)